Topline:
A recent study within the US Department of Veterans Affairs health care system has revealed that acetylcholinesterase inhibitors (AChEIs), commonly prescribed for Alzheimer's disease (AD), could potentially lower the risk of developing age-related macular degeneration (AMD) among veterans. This groundbreaking research suggests a new avenue for AMD prevention strategies, shedding light on the benefits of AChEIs beyond their current use.
